GSE147876 GSE147877 enzalutamide MR42D 4 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE147876_GSE147877_enzalutamide_MR42D_4_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE147876_GSE147877_enzalutamide_MR42D_4_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

GOLGA2 pseudogene 7

Gene

FGD5 antisense RNA 1

Gene

MT-ATP6 pseudogene 1

Gene

FSHD region gene 1 family member C, pseudogene

Gene

ribosomal protein S2 pseudogene 5

Gene

NF-kappaB interacting lncRNA

Gene

MT-ND2 pseudogene 28

Gene

uncharacterized LOC124903135

Gene

uncharacterized LOC105377329

Gene

uncharacterized LOC101930100

  • Gene

    GOLGA2 pseudogene 7


  • Gene

    FGD5 antisense RNA 1


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    FSHD region gene 1 family member C, pseudogene


  • Gene

    ribosomal protein S2 pseudogene 5


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    uncharacterized LOC124903135


  • Gene

    uncharacterized LOC105377329


  • Gene

    uncharacterized LOC101930100

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.